Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

N-protein presents early in blood, dried blood and saliva during asymptomatic and symptomatic SARS-CoV-2 infection.

Autor: Shan D; Quanterix Corporation, Billerica, MA, USA., Johnson JM; Quanterix Corporation, Billerica, MA, USA., Fernandes SC; Quanterix Corporation, Billerica, MA, USA., Suib H; Quanterix Corporation, Billerica, MA, USA., Hwang S; Quanterix Corporation, Billerica, MA, USA., Wuelfing D; Quanterix Corporation, Billerica, MA, USA., Mendes M; Quanterix Corporation, Billerica, MA, USA., Holdridge M; Quanterix Corporation, Billerica, MA, USA., Burke EM; Quanterix Corporation, Billerica, MA, USA., Beauregard K; Quanterix Corporation, Billerica, MA, USA., Zhang Y; Quanterix Corporation, Billerica, MA, USA., Cleary M; Quanterix Corporation, Billerica, MA, USA., Xu S; Quanterix Corporation, Billerica, MA, USA., Yao X; Quanterix Corporation, Billerica, MA, USA., Patel PP; Quanterix Corporation, Billerica, MA, USA., Plavina T; Quanterix Corporation, Billerica, MA, USA., Wilson DH; Quanterix Corporation, Billerica, MA, USA., Chang L; Quanterix Corporation, Billerica, MA, USA., Kaiser KM; Institute of Innate Immunity, University of Bonn, Bonn, Germany., Nattermann J; Institute of Innate Immunity, University of Bonn, Bonn, Germany.; German Center for Infection Research (DZIF), Bonn, Germany., Schmidt SV; Department of Internal Medicine I, University of Bonn, Bonn, Germany., Latz E; Department of Internal Medicine I, University of Bonn, Bonn, Germany.; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany., Hrusovsky K; Quanterix Corporation, Billerica, MA, USA., Mattoon D; Quanterix Corporation, Billerica, MA, USA., Ball AJ; Quanterix Corporation, Billerica, MA, USA. aball@quanterix.com.

Publikováno v: Nature communications [Nat Commun] 2021 Mar 26; Vol. 12 (1), pp. 1931. Date of Electronic Publication: 2021 Mar 26.

Probing Anti-inflammatory Properties Independent of NF-κB Through Conformational Constraint of Peptide-Based Interleukin-1 Receptor Biased Ligands.

Autor: Geranurimi A; Département de Chimie, Université de Montréal, Montréal, QC, Canada., Cheng CWH; Department of Pharmacology and Therapeutics, McGill University, Montréal, QC, Canada.; CHU Sainte-Justine Research Centre, Montréal, QC, Canada.; Hôpital Maisonneuve-Rosemont Research Centre, Montréal, QC, Canada., Quiniou C; CHU Sainte-Justine Research Centre, Montréal, QC, Canada., Zhu T; CHU Sainte-Justine Research Centre, Montréal, QC, Canada., Hou X; CHU Sainte-Justine Research Centre, Montréal, QC, Canada., Rivera JC; CHU Sainte-Justine Research Centre, Montréal, QC, Canada.; Hôpital Maisonneuve-Rosemont Research Centre, Montréal, QC, Canada., St-Cyr DJ; Département de Chimie, Université de Montréal, Montréal, QC, Canada., Beauregard K; Département de Chimie, Université de Montréal, Montréal, QC, Canada., Bernard-Gauthier V; Département de Chimie, Université de Montréal, Montréal, QC, Canada., Chemtob S; Department of Pharmacology and Therapeutics, McGill University, Montréal, QC, Canada.; CHU Sainte-Justine Research Centre, Montréal, QC, Canada.; Hôpital Maisonneuve-Rosemont Research Centre, Montréal, QC, Canada.; Departments of Pediatrics, Pharmacology and Physiology, and Ophthalmology, Université de Montréal, Montréal, QC, Canada., Lubell WD; Département de Chimie, Université de Montréal, Montréal, QC, Canada.

Publikováno v: Frontiers in chemistry [Front Chem] 2019 Feb 13; Vol. 7, pp. 23. Date of Electronic Publication: 2019 Feb 13 (Print Publication: 2019).

VRQ397 (CRAVKY): a novel noncompetitive V2 receptor antagonist.

Autor: Rihakova, L., C. Quiniou, Hamdan, F. F., Kaul, R., Brault, S., X. Hou, Lahaie, I., Sapieha, P., Hamel, D., Z. Shao, Gobeil Jr., F., Hardy, P., Joyal, J.-S., Nedev, H., Duhamel, F., Beauregard, K., Heveker, N., Saragovi, H. U., Guillon, G., Bouvier, M.

Publikováno v: American Journal of Physiology: Regulatory, Integrative & Comparative Physiology; Oct2009, Vol. 297, pR1009-R1018, 10p, 6 Graphs

SARS-CoV-2-Specific Immune Responses in Vaccination and Infection during the Pandemic in 2020–2022.

Autor: Inoue, Wakana¹ (AUTHOR) g7123001be@edu.teu.ac.jp, Kimura, Yuta¹ (AUTHOR) y_kimura@tmig.or.jp, Okamoto, Shion¹ (AUTHOR) g712300262@edu.teu.ac.jp, Nogimori, Takuto² (AUTHOR) tnogimori@nibiohn.go.jp, Sakaguchi-Mikami, Akane¹ (AUTHOR) amikami@stf.teu.ac.jp, Yamamoto, Takuya^2,3,4 (AUTHOR) yamamotot2@nibiohn.go.jp, Tsunetsugu-Yokota, Yasuko^1,2,5 (AUTHOR) yokotaysk@stf.teu.ac.jp

Publikováno v: Viruses (1999-4915). Mar024, Vol. 16 Issue 3, p446. 17p.